Delcath SystemsDCTH +5.12%70 Current Ratio is 11.24 as of Mar. 2026, which is 670% above its 10-year median of 1.46. GuruFocus rates DCTH with a GF Score™ of 70/100 and a GF Value™ of $36.72 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Delcath Systems ranks better than 94.85% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Delcath Systems's current ratio for the quarter that ended in Mar. 2026 was 11.24.
Delcath Systems has a current ratio of 11.24. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Delcath Systems's Current Ratio or its related term are showing as below:
DCTH'
s Current Ratio Range Over the Past 10 Years
Min: 0.09 Med: 1.46 Max: 15.95
Current: 11.24
During the past 13 years, Delcath Systems's highest Current Ratio was 15.95. The lowest was 0.09. And the median was 1.46.
DCTH's Current Ratio is ranked better than 94.85% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 2.485
vs DCTH: 11.24
Delcath Systems (NAS:DCTH) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Delcath Systems Current Ratio Related Terms
Delcath Systems Current Ratio Historical Data
* Premium members only.
The historical data trend for Delcath Systems's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Delcath Systems's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delcath Systems Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Current Ratio distribution charts can be found below:
* The bar in red indicates where Delcath Systems's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delcath Systems (DCTH) has a Current Ratio of 11.24 as of Mar. 2026. This is 670% above median its historical median of 1.46. Over the past decade, Delcath Systems' Current Ratio has ranged from 0.09 to 15.95. According to the industry distribution chart, Delcath Systems ranks #44 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 5.2%.
Is Delcath Systems' Current Ratio too high?
Delcath Systems' current Current Ratio of 11.24 is 670% above median its 10-year median of 1.46. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 15.95. The Medical Devices & Instruments industry median Current Ratio is 2.49. Delcath Systems' value of 11.24 is 352.3% above this industry median. Based on the distribution chart, Delcath Systems ranks #44 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Delcath Systems has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Delcath Systems' Current Ratio compare to OFIX and VMD?
According to the Medical Devices & Instruments industry distribution chart, Delcath Systems ranks #44 out of 854 companies for Current Ratio. This places Delcath Systems in the top 5% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.49. Delcath Systems' value of 11.24 is 352.3% above this benchmark. Historically, Delcath Systems' own Current Ratio has ranged from 0.09 to 15.95 over the past decade. While the company's 10-year median is 1.46 vs. the industry median of 2.49, Delcath Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delcath Systems's current Current Ratio of 11.24 is 352.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delcath Systems's current Current Ratio is 11.24, which is 670% above median its own 10-year median of 1.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delcath Systems stock overvalued right now?
Based on GuruFocus' analysis, Delcath Systems (DCTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $36.72, compared to a current price of $12.94 — trading 64.8% below its estimated fair value. The current Current Ratio is 11.24, which is 670% above median its 10-year median of 1.46 and 352.3% above the Medical Devices & Instruments industry median of 2.49. Delcath Systems' overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Delcath Systems (DCTH), the current Current Ratio is 11.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Delcath Systems (DCTH) Overvalued in 2026?
Based on GuruFocus' analysis, Delcath Systems stock appears to be undervalued.
The current stock price of $12.94 is trading 64.8% below its estimated GF Value™ of $36.72.
GuruFocus considers Delcath Systems to be Significantly Undervalued.
Key valuation signals for DCTH:
Current Ratio: 11.24 (670% above median its 10-year median of 1.46)
GF Value™: $36.72 vs. price of $12.94 (64.8% below fair value)
Industry Position: 352.3% above the Medical Devices & Instruments median (#44 of 854)
No single metric tells the full story. See the DCTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
70GF Score
Get the complete analysis for DCTH
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DCTH has been successfully added to your 
